ORBIMED ADVISORS LLC

Position in ASND — Ascendis Pharma A/S

CIK 1055951 New York, NY

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$41,623,599

+$4,951,224 QoQ

Shares Held

181,977

+5.8% QoQ

Ownership

0.277%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 17.769278535199504.ToString("F0")% Shared 0.ToString("F0")% None 82.2307214648005.ToString("F0")%

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names. ASND ranks #20 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$488,832,498
2	ELVN	Enliven Therapeutics, Inc.	7,959,538	$312,013,889
3	SION	Sionna Therapeutics, Inc.	3,530,702	$141,545,843
4	MBX	MBX Biosciences, Inc.	3,637,887	$108,590,926
5	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$104,824,037
6	ARGX	Argenx SE	136,900	$99,971,225
7	CMPX	Compass Therapeutics, Inc.	15,219,994	$80,513,768
8	GPCR	Structure Therapeutics Inc.	1,475,403	$71,114,424

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$41,623,599	181,977	+5.8%	Shares	Defined	2026-05-15
2025-12-31	$36,672,375	171,977	-10.4%	Shares	Defined	2026-02-17
2025-09-30	$38,152,633	191,905	+457.9%	Shares	Defined	2025-11-14
2025-06-30	$5,937,440	34,400	-92.3%	Shares	Sole	2025-08-14
2021-06-30	$58,915,851	447,859	-11.3%	Shares	Defined	2021-08-16
2021-03-31	$65,104,891	505,159	+50.1%	Shares	Defined	2021-05-17
2020-12-31	$56,121,470	336,500	-54.2%	Shares	Defined	2021-02-16
2020-09-30	$113,348,040	734,500	-53.0%	Shares	Defined	2020-11-16
2020-06-30	$231,165,629	1,562,986	-52.5%	Shares	Defined	2020-08-14
2020-03-31	$370,194,114	3,287,400	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.